Public Policy

CDC Shakeup: Monarez’s Exit Sparks Vaccine Policy Debate
Public Policy CDC Shakeup: Monarez’s Exit Sparks Vaccine Policy Debate

I'm thrilled to sit down with Faisal Zain, a renowned healthcare expert with a deep background in medical technology. With years of experience in the manufacturing of medical devices for diagnostics and treatment, Faisal has been at the forefront of innovation in the field. Today, we'll

How Will Colorado's New Healthcare Rules Impact Providers?
Public Policy How Will Colorado's New Healthcare Rules Impact Providers?

In the heart of Colorado's bustling healthcare sector, a seismic shift is underway as new regulations reshape the operational landscape for providers across the state, affecting over 2,000 licensed entities. With hospitals, nursing facilities, and home care agencies grappling with evolving

FDA's New Accelerated Pathway: Risks and Rewards for Pharma
Public Policy FDA's New Accelerated Pathway: Risks and Rewards for Pharma

Imagine a world where life-saving drugs reach patients in mere months rather than years, addressing urgent medical crises with unprecedented speed, and transforming the landscape of healthcare delivery. This vision is becoming a reality through the U.S. Food and Drug Administration's latest

AI as Co-Pilot in Regulatory Medical Writing Webinar
Public Policy AI as Co-Pilot in Regulatory Medical Writing Webinar

Introduction to the Evolving Landscape of Medical Writing Imagine a world where regulatory medical writing, a cornerstone of the pharmaceutical and healthcare industries, achieves unprecedented speed and precision, delivering life-saving therapies to patients faster than ever before. This vision is

FDA Suspends Valneva’s Chikungunya Vaccine Over Safety Risks
Public Policy FDA Suspends Valneva’s Chikungunya Vaccine Over Safety Risks

What happens when a long-awaited solution to a debilitating disease turns into a potential threat? In a stunning turn of events, the U.S. Food and Drug Administration (FDA) has suspended the license of Ixchiq, the first chikungunya vaccine approved in the U.S., developed by Valneva, a France-based

Breaking Data Silos in Behavioral Health for Better Care
Public Policy Breaking Data Silos in Behavioral Health for Better Care

In the intricate landscape of behavioral health, delivering high-quality care depends heavily on the ability to share and access patient information seamlessly across diverse providers and settings, yet a persistent and daunting obstacle stands in the way: data silos. These isolated repositories of

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later